Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. Experimentation is vital.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

NOVEMBER 5, 2015

As a child I felt no particular interest in pharmaceuticals, telecommunications, computers, oil and gas, health and beauty aids, medical devices, airlines, or shipbuilding, all of which I’ve simulated or war-gamed. I didn’t ponder whether shareholder wealth should be the sole fiduciary duty of top management.

Career 8

Career Seminar Self-aware Telecommunications 8

Harvard Business Review

SEPTEMBER 15, 2014

Instead of passive subscribers, it created “communities of friends” who generated new story ideas and collaborated with Fast Company staff to develop themes of the “new management revolution.”. Informal leadership Managing people' Like its rivals, Best Buy tended to sell consumer electronics from a strongly male perspective.

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

MARCH 24, 2011

What makes the matter fascinating to industry watchers, approximately their equivalent of the Charlie Sheen supernova, is that Gupta served three terms as managing director of McKinsey & Co., In his tenure as McKinsey's worldwide managing director, Gupta displayed macher-like ambition not just for himself but even more so for his firm.

McKinsey 14

McKinsey Consultative Waterman Intellectual Capital 14

Harvard Business Review

SEPTEMBER 19, 2016

This logic and the institutions that reinforce it, like competitive markets and the rule of law, have transformed the world and lifted billions of people from poverty. You have to approach these problems as a manager and do the best analysis you can, including hard-headed financial analysis. But perhaps managers have no choice.

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement. The largest payments were from Pfizer ($2.3 billion) and GlaxoSmithKline ($3 billion).

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

FEBRUARY 3, 2017

The business model of research-based pharmaceutical companies is under significant pressure. This strategy will tap potential growth in emerging markets, limit the risks of misconduct, and improve public trust in the industry. However, it also reflects stronger pressures to lower medicine costs in traditional pharmaceutical markets.

Reputation 8

Reputation Pharmaceuticals Price Business Model 8